logo
Plus   Neg
Share
Email

Coca-Cola Company Shares Up 3% On Q1 Results; Affirms FY Guidance

The Coca-Cola Company (KO) reported that its first-quarter comparable EPS from continuing operations rose 2% to $0.48, despite an 11-point currency headwind. EPS included an estimated 2 cent benefit from timing, primarily from the bottler inventory build related to Brexit. On average, 20 analysts polled by Thomson Reuters expected the company to report profit per share of $0.46 for the quarter. Analysts' estimates typically exclude special items.

For the first-quarter, reported net revenues increased 5% to $8.0 billion, and organic revenues were up 6% including a 2% benefit from timing. Analysts expected revenue of $7.89 billion for the quarter.

James Quincey, CEO, said: "We remain confident in our full year guidance as we continue to make progress on our transformation as a consumer-centric total beverage company."

Shares of Coca-Cola Company were up more than 3% in pre-market trade on Tuesday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT
>